FREQUENCY OF GESTATIONAL TROPHOBLASTIC DISEASE IN FIRST TRIMESTER MISCARRIAGES
Main Article Content
Keywords
gestational trophoblastic disease,, first trimester, miscarriages
Abstract
Introduction: Gestational trophoblastic disease (GTD) is a group of disorders that range from the premalignant condition of complete and partial molar pregnancies to the malignant conditions of invasive mole, choriocarcinoma, and the extremely rare placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT).
Objective: To determine the frequency of gestational trophoblastic disease in first trimester miscarriages
Setting: Department of Obstetrics and Gynaecology HMC, Peshawar.
Study Design: Cross-sectional study
Duration of Study: Six months from 30th August 2021 to 30th February 2022.
Material and Methods: All women were subjected to detailed history and clinical examination followed by relevant investigations as per antenatal protocols. Laboratory investigations were included CBC, histopathology and beta HCG. Women who failed to maintain follow up were dropped from the study. All women were managed as per RCOG guidelines
Results: Our study shows that mean age was 27 years with a standard deviation ± 5.92. 113(69%) patients were primi gravida while 51(31%) patients were multi gravida. 108(66%) patients were primi para while 56(34%) patients were multi para. 10(6%) patients had gestational trophoblastic disease while 154(94%) patients didn’t have gestational trophoblastic disease.
Conclusion: Our study concluded that the frequency of gestational trophoblastic disease was 6% in first trimester miscarriages
References
2. Tidy JA, Hancock BW, Ansink A, Hammond CB, Ilancheran A, Jauniaux ER, et. al. The management of gestational trophoblastic neoplasia. Royal College of Obstetricians and Gynaecologists, Guideline Number 38. RCOG Guideline. 2004.
3. Tidy JA, Hancock BW, Ansink A, Hammond CB, Ilancheran A, Jauniaux ER, et. al. The management of gestational trophoblastic neoplasia. Royal College of Obstetricians and Gynaecologists, Guideline Number 38. RCOG Guideline. 2004.
4. Zakaria A, Hemida R, Elrefaie W, Refaie E. Incidence and outcome of gestational trophoblastic disease in lower Egypt. African Health Sciences. 2020 20;20(1):73-82
5. Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gyn oncol. 2009;112(3):654-62.
6. Jagtap SV, Aher V, Gadhiya S, Jagtap SS. Gestational trophoblastic disease-Clinicopathological study at tertiary care hospital. Journal of clinical and diagnostic research: JCDR. 2017;11(8):EC27.
7. Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gyn oncol. 2009;112(3):654-62.
8. Deep JP, Sedhai LB, Napit J, Pariyar J. Gestational trophoblastic disease. J. Chit Med Col. 2013;3(2):4-11.
9. Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am. J. Obstet. Gynecol. 2010;203(6):531-9.
10. Ngan H, Seckl M, Berkowitz R, Xiang Y, Golfier F, Sekharan P et al. Update on the diagnosis and management of gestational trophoblastic disease. International Journal Of Gynecology & Obstetrics, 2018;143:79-85.
11. Creinin MD. Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion. Contraception 2000;62:117-24.
12. Wreczycka-Cegielny P, Cegielny T, Oplawski M, Sawicki W, Kojs Z. Current treatment options for advanced choriocarcinoma on the basis of own case and review of the literature. Ginekol Pol. 2018;89(12):711-715..
13. Al Riyami N, Al Riyami M, Al Hajri AT, Al Saidi S, Salman B, Al Kalbani M. Gestational Trophoblastic Disease at Sultan Qaboos University Hospital: Prevalence, Risk Factors, Histological Features, Sonographic Findings, and Outcomes. Oman Med J. 2019 May;34(3):200-204.